BERTOMORO, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 2.805
AS - Asia 885
EU - Europa 583
AF - Africa 232
SA - Sud America 201
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 11
Totale 4.732
Nazione #
US - Stati Uniti d'America 2.701
SG - Singapore 231
CN - Cina 212
HK - Hong Kong 146
BR - Brasile 141
VN - Vietnam 113
DE - Germania 67
FI - Finlandia 67
IT - Italia 67
SE - Svezia 62
FR - Francia 36
GB - Regno Unito 34
CI - Costa d'Avorio 31
PL - Polonia 26
RU - Federazione Russa 23
NL - Olanda 19
TR - Turchia 17
UA - Ucraina 15
AT - Austria 13
BE - Belgio 11
JM - Giamaica 11
LC - Santa Lucia 11
MX - Messico 11
SK - Slovacchia (Repubblica Slovacca) 11
CH - Svizzera 10
EC - Ecuador 10
EG - Egitto 10
ES - Italia 10
NE - Niger 10
PE - Perù 10
ZA - Sudafrica 10
DZ - Algeria 9
IE - Irlanda 9
MG - Madagascar 9
MW - Malawi 9
PK - Pakistan 9
VC - Saint Vincent e Grenadine 9
AM - Armenia 8
AR - Argentina 8
BA - Bosnia-Erzegovina 8
CA - Canada 8
CM - Camerun 8
JP - Giappone 8
LV - Lettonia 8
MA - Marocco 8
NO - Norvegia 8
YT - Mayotte 8
AE - Emirati Arabi Uniti 7
CG - Congo 7
CO - Colombia 7
CU - Cuba 7
CV - Capo Verde 7
DJ - Gibuti 7
HU - Ungheria 7
IN - India 7
KG - Kirghizistan 7
PT - Portogallo 7
UZ - Uzbekistan 7
AD - Andorra 6
AO - Angola 6
BO - Bolivia 6
BY - Bielorussia 6
HR - Croazia 6
IL - Israele 6
KR - Corea 6
KZ - Kazakistan 6
LA - Repubblica Popolare Democratica del Laos 6
PY - Paraguay 6
TZ - Tanzania 6
VE - Venezuela 6
AU - Australia 5
AZ - Azerbaigian 5
BD - Bangladesh 5
BF - Burkina Faso 5
BJ - Benin 5
DK - Danimarca 5
GE - Georgia 5
GT - Guatemala 5
IS - Islanda 5
LU - Lussemburgo 5
LY - Libia 5
MN - Mongolia 5
MY - Malesia 5
NI - Nicaragua 5
PH - Filippine 5
PR - Porto Rico 5
RE - Reunion 5
RW - Ruanda 5
SA - Arabia Saudita 5
SN - Senegal 5
SO - Somalia 5
SY - Repubblica araba siriana 5
TH - Thailandia 5
TL - Timor Orientale 5
TT - Trinidad e Tobago 5
UG - Uganda 5
XK - ???statistics.table.value.countryCode.XK??? 5
ZM - Zambia 5
BZ - Belize 4
ET - Etiopia 4
Totale 4.577
Città #
Fairfield 463
Ashburn 265
Chandler 237
Woodbridge 204
Singapore 159
Cambridge 157
Seattle 155
Wilmington 155
Houston 146
Hong Kong 138
Ann Arbor 85
Dong Ket 85
Jacksonville 68
Beijing 66
Santa Clara 64
Boardman 53
Princeton 51
San Diego 38
Abidjan 30
Medford 28
Nanjing 28
Padova 24
Helsinki 22
Bytom 21
Los Angeles 19
São Paulo 17
Buffalo 16
Munich 16
Roxbury 15
New York 13
Des Moines 12
Castries 11
Changsha 11
Norwalk 11
Nuremberg 11
Cairo 9
Hefei 9
Kingston 9
Kingstown 9
Antananarivo 8
Chicago 8
Dublin 8
Hebei 8
London 8
Niamey 8
Redondo Beach 8
Ho Chi Minh City 7
Lilongwe 7
Shenyang 7
Washington 7
Yerevan 7
Andorra la Vella 6
Bishkek 6
Boston 6
Djibouti 6
Douala 6
Havana 6
Istanbul 6
Lima 6
Nanchang 6
Phoenix 6
Praia 6
Riga 6
Tashkent 6
Vientiane 6
Baku 5
Brazzaville 5
Cotonou 5
Dakar 5
Dar es Salaam 5
Dili 5
Hanoi 5
Kampala 5
Kigali 5
Luanda 5
Lusaka 5
Managua 5
Minsk 5
Rio de Janeiro 5
Ulan Bator 5
Abu Dhabi 4
Amsterdam 4
Belize City 4
Bratislava 4
Brussels 4
Guayaquil 4
Hargeisa 4
Jeddah 4
Jiaxing 4
Johannesburg 4
Las Vegas 4
Luxembourg 4
Nutley 4
Ouagadougou 4
Podgorica 4
Reykjavik 4
San Francisco 4
Santa Cruz 4
Tokyo 4
Turku 4
Totale 3.260
Nome #
Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease. 218
Type 2B von Willebrand disease with or without large multimers: A distinction of the two sides of the disorder is long overdue 177
A 29-year-old woman with persistent thrombocytopenia 172
Abnormally large von Willebrand factor multimers in Henoch-Schönlein purpura. 171
Type 1 von Willebrand disease due to reduced von Willebrand factor synthesis and/or survival: observations from a case series. 159
A novel von Willebrand factor mutation (11372S) associated with type 2B-like von Willebrand disease: An elusive phenotype and a difficult diagnosis 149
Spectrum of 5’UTR mutations in ANKRD26 gene in patients with inherited thrombocytopenia: c.-140C>G mutation is more frequent than expected 149
Associated risk factors and arterial occlusions in patients with von Willebrand disease: Analysis of the literature and report of two cases 148
Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia. 146
Acquired factor VIII:C inhibitor in a patient with Sjögren's syndrome: successful treatment with steroid and immunosuppressive therapy. 145
Spontaneous recurrent intracranial haemorrhage in a woman with type 2B von Willebrand disease: A clinical case and a brief literature review 143
Abnormal collagen binding activity of 2A von Willebrand factor: evidence that the defect depends only on the lack of large multimers. 133
Combined partial exon skipping and cryptic splice site activation as a new molecular mechanism for recessive type 1 von Willebrand disease. 128
EDTA dependent pseudothrombocytopenia caused by antibodies against the cytoadhesive receptor of platelet gpIIB-IIIA. 127
Type IIb von Willebrand disease: role of qualitative defects in atherosclerosis and endothelial dysfunction. 123
Do hemophilia A and von Willebrand disease protect against carotid atherosclerosis? A comparative study between coagulopathics and normal subjects by means of carotid echo-color Doppler scan. 123
Type 2M von Willebrand disease variant characterized by abnormal von willebrand factor multimerization. 121
Which assay is the most suitable to investigate von Willebrand factor functional activity? 119
The Bleeding Assessment Tool and laboratory data in the characterisation of a female with inherited haemophilia A 119
Type I Padua: a new variant of von Willebrand's disease. 118
Combined exon skipping and cryptic splice activation as a new molecular mechanism for recessive type 1 von Willebrand disease. 115
Demonstration that venous occlusion fails to release von Willebrand factor multimers. 114
An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant. 113
Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co-factor activity? 113
Re-evaluation of the therapeutic efficacy of DDAVP in type IIB von Willebrand's disease. 113
A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor 112
Different organization of von Willebrand factor oligomers in type-2A and -2B von Willebrand disease variants: effects of DDAVP infusion and protease inhibitors. 111
Lack of multimer organization of von Willebrand factor in an acquired von Willebrand syndrome. 110
An apparent silent nucleotide substitution (c.7056C>T) in the von Willebrand factor gene is responsible for type 1 von Willebrand disease. 107
First report of combined factor VII Padua defect and von Willebrand's disease due to casual association of the two defects. 105
A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers. 104
Fainting induces an acute increase in the concentration of plasma factor VIII and von Willebrand factor. 103
On the release of von Willebrand factor from endothelial cells after venous occlusion. 103
Pregnancy-induced worsening of thrombocytopenia in a patient with type IIB von Willebrand's disease. 89
Identifying carriers of type 2N von Willebrand disease: procedures and significance. 89
DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor. 88
On the discrepant post-DDAVP increase of FVIII:C and von Willebrand factor in some patients with severe von Willebrand's disease. 85
Discrepant increase in factor VIII: C and von Willebrand factor after DDAVP infusion in a patient with variant von Willebrand's disease. 83
Totale 4.745
Categoria #
all - tutte 16.022
article - articoli 16.022
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.044


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021402 0 0 0 40 11 33 37 29 52 56 39 105
2021/2022563 23 59 84 34 41 44 33 55 19 12 77 82
2022/2023449 80 60 10 46 78 52 2 33 48 1 36 3
2023/2024213 4 39 27 21 25 31 19 9 1 2 17 18
2024/2025900 3 71 40 44 134 28 40 57 63 30 158 232
2025/20261.005 156 239 460 150 0 0 0 0 0 0 0 0
Totale 4.745